Non classé

FDA okays Lilly's antibody treatment for Covid-19


The FDA has issued an emergency use authorization for Eli Lilly and Co’s monoclonal antibody therapy bamlanivimab to treat coronavirus infections in adults and children. Source: SwissUXNews